homocysteine has been researched along with Budd-Chiari Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertino, G; Borzì, AM; Catania, VE; Drago, F; La Greca, G; Latteri, S; Malaguarnera, G; Malaguarnera, M | 1 |
Akarca, U; Balým, Z; Batur, Y; Can, C; Colak, Y; Ersoz, G; Gunsar, F; Karasu, Z; Oruc, N; Tokat, Y | 1 |
Günther, G; Heller, C; Junker, R; Kreuz, W; Kurnik, K; Nowak-Göttl, U; Schobess, R | 1 |
3 other study(ies) available for homocysteine and Budd-Chiari Syndrome
Article | Year |
---|---|
Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis.
Topics: Adult; Aged; Biomarkers, Tumor; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Cholesterol, LDL; Female; Folic Acid; Homocysteine; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Prognosis; Vitamin B 12; Vitamin B 6 | 2019 |
Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome.
Topics: Adult; Budd-Chiari Syndrome; Case-Control Studies; Factor V; Female; Homocysteine; Humans; Male; Middle Aged; Mutation; Prothrombin; Sex Factors; Turkey | 2006 |
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
Topics: Antibodies, Anticardiolipin; Antithrombins; Budd-Chiari Syndrome; Case-Control Studies; Confidence Intervals; Factor V; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Infant; Infant, Newborn; Lipoprotein(a); Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Portal Vein; Prospective Studies; Protein C; Protein S; Prothrombin; Renal Veins; Venous Thrombosis | 2000 |